Clinical Trial Update: Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP) [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating non-inferiority of low-dose HIPEC versus high-dose HIPEC for pseudomyxoma peritonei. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomyxoma Peritonei

Snippet

Sponsor: University of Southampton | Conditions: Pseudomyxoma Peritonei | Phase 3 | Status: RECRUITING